Clinical Trial Update: A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study [Phase 3]

View source ↗

Summary

Phase 3 trial of bardoxolone methyl in diabetic kidney disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Diabetic Kidney Disease | Phase 3 | Status: TERMINATED